Verrica Pharmaceuticals
VRCA
VRCA
49 hedge funds and large institutions have $29.9M invested in Verrica Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
37% less call options, than puts
Call options by funds: $86K | Put options by funds: $137K
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Holders
49
Holding in Top 10
–
Calls
$86K
Puts
$137K
Top Buyers
| 1 | +$532K | |
| 2 | +$198K | |
| 3 | +$135K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$93.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$84.8K |
Top Sellers
| 1 | -$864K | |
| 2 | -$845K | |
| 3 | -$783K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$469K |
| 5 |
Millennium Management
New York
|
-$174K |